Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects With Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings
1 other identifier
observational
800
1 country
1
Brief Summary
The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 9, 2011
CompletedFirst Posted
Study publicly available on registry
May 12, 2011
CompletedMay 12, 2011
May 1, 2011
4 months
May 9, 2011
May 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients who maintain US NCEP ATP III LDL-C target goals after long-term therapy
Up to 8 years
Secondary Outcomes (3)
LDL-cholesterol levels
Up to 8 years
HDL-cholesterol levels
Up to 8 years
Proportion of patients having raised levels of serum CK or ALT
Up to 8 years
Eligibility Criteria
Patients from primary care and specialist clinics
You may qualify if:
- Primary hypercholesterolemia
- Subjects from first rosuvastatin Registry study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (1)
Research Site
Singapore, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DR ARTHUR TAN, MBBS
ARTHUR TAN HEART CLINIC, GLENEAGLES MEDICAL CENTRE
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 9, 2011
First Posted
May 12, 2011
Study Start
August 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
May 12, 2011
Record last verified: 2011-05